Solid Biosciences Inc
(NAS:SLDB)
$
5.94
0.28 (4.95%)
Market Cap: 229.26 Mil
Enterprise Value: 53.48 Mil
PE Ratio: 0
PB Ratio: 1.19
GF Score: 41/100 Solid Biosciences Inc at Barclays Virtual Gene Editing & Therapy Summit Transcript
May 24, 2023 / 03:30PM GMT
Release Date Price:
$6.01
(-2.91%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
Good morning, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at the Barclays. Thank you very much for joining the 7th Gene Editing and Gene Therapy Summit at the Barclays. I would like to first take this opportunity to thank all the investors, companies, also, especially our event team and the corporate access team who made this event possible.
With that, I would like to introduce our next presenting company, Solid. With us today, we have Bo Cumbo, President and Chief Executive Officer. We also have Kevin Tan, Chief Financial Officer. Thank you both for joining us today.
Kevin Tan
Solid Biosciences Inc. - CFO & Treasurer
Thanks for having us.
Alexander G. Cumbo
Solid Biosciences Inc. - President, CEO & Director
Thank you, Gena.
Questions & Answers
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
So maybe, Bo, I will start with DMD
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot